secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2021-10-15T23:59:59+00:00
Accession:  0001683168-21-004865
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences amends Pharmsynthez agreement; terminates prior work order, enters new one with $40K payment
--------------------------------------------------------------------------------

- Entered Amendment Number One to Master Service Agreement to terminate the prior Work Order with Pharmsynthez.
- Executed a new Second Work Order for XCART technology development services upon written request.
- Made a one-time $40,000 payment: $21,000 settles prior obligations, $19,000 creditable against future costs.
- No further services under prior Work Order; all future work requires new work orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316821004865/0001683168-21-004865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316821004865/xenetic_i8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-004865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer